| Literature DB >> 33754311 |
Sakshi Sachdeva1, Anita Saxena2,3, Samir Shakya1, Sivasubramanian Ramakrishnan1, Saurabh K Gupta1, Shyam S Kothari1.
Abstract
OBJECTIVE: To study the impact of coronavirus disease 2019 (COVID-19) pandemic on the utilization of pediatric cardiac care services and to determine the role of teleconsultation services in delivering healthcare in this subset of population.Entities:
Keywords: COVID-19; Congenital heart disease; Pediatric cardiology; Teleconsultation
Year: 2021 PMID: 33754311 PMCID: PMC7985229 DOI: 10.1007/s12098-021-03702-y
Source DB: PubMed Journal: Indian J Pediatr ISSN: 0019-5456 Impact factor: 1.967
Comparison of number of patients utilizing inpatient and outpatient pediatric cardiac care services between April 1 and July 31, in 2020 and 2019
| 2020 (n) | 2019 (n) | Percent reduction | |
|---|---|---|---|
| OPD/Teleconsultation | 1079 | 7176 | 84.9% |
| Indoor admissions | 66 | 189 | 65% |
| Total CHD surgeries | 50 | 409 | 87.8% |
| Emergency CHD surgeries | 35 | 58 | 39.6% |
| Transcatheter intervention | 14 | 87 | 83.9% |
| Diagnostic catheterization | 2 | 131 | 98.4% |
CHD Congenital heart disease; OPD Outpatient department
Breakup of patients (consulted through telecommunication) into broad hemodynamic subgroups
| Hemodynamic subset | N (%) |
|---|---|
| CCHD, reduced PBF | 265 (24.5%) |
| CCHD, increased PBF | 57 (5.2%) |
| ACHD, increased PBF | 251 (23.2%) |
| Valvar lesions | 83 (7.6%) |
| Complex CCHD, asymptomatic | 13 (1.2%) |
| Postoperated, asymptomatic | 188 (17.4%) |
| Postoperated, symptomatic | 13 (1.2%) |
| Stage-I palliation (BTS/BDG/PAB) | 89 (8.2%) |
| Postcatheter intervention | 36 (3.3%) |
| DCMP | 31 (2.8%) |
| IPAH/Eisenmenger syndrome | 17 (1.5%) |
| Arrhythmia/CHB, stable | 14 (1.3%) |
| Misc (NSAA, allied specialities, HCM, postchemotherapy, hemoptysis) | 22 (2%) |
ACHD Acyanotic congenital heart disease; BDG Bidirectional Glenn; BTS Blalock Taussig shunt; CCHD Cyanotic congenital heart disease; CHB Congenital heart block; DCMP Dilated cardiomyopathy; HCM Hypertrophic cardiomyopathy; IPAH Idiopathic pulmonary artery hypertension; NSAA Non-specific aorto-arteritis; PAB Pulmonary artery band; PBF Pulmonary blood flow
Investigations and evaluations done locally to help in teleconsultation for CHD care
| Investigations | Utility |
|---|---|
| Weight | Optimization of medications according to weight |
| Oxygen saturation | Distinguish cyanotic CHD with increased pulmonary blood flow, from cyanotic CHD; assess worsening hemodynamics and need of intervention in TOF physiology |
| Blood pressure | To assess optimal hypertension control following relief of aortic obstruction in children with coarctation of aorta and aortoarteritis |
| Hemoglobin | Decide blood transfusion in patients with heart failure and cyanotic spells |
| ASLO, CRP, ESR | To assess recurrence of acute rheumatic fever in children with RHD |
| CRP, ESR | To assess recurrence of disease activity in patients with Takayasu arteritis |
| PT/INR | Optimisation of anticoagulation in patients with prosthetic heart valve implantation |
| ECG | For rhythm assessment in patients with pacemaker implantation |
ASLO Antistreptolysin O; CHD Congenital heart disease; CRP C-reactive protein; ECG Electrocardiogram; ESR Erythrocyte sedimentation rate; PT/INR Prothrombin time/ International normalised ratio; RHD Rheumatic heart disease; TOF Tetralogy of Fallot
Action for patients attending teleconsultations during the lockdown period
| Outcome | N (%) |
|---|---|
| No active intervention | 806 (74.6%) |
| Medication change | 131 (12.1%) |
| Noncardiac issues addressed | 50 (3.9%) |
| Local management | 40 (3.7%) |
| Cath/intervention redating | 25 (2.3%) |
| Patients asked to visit hospital | 26 (2.4%) |
| Suture-related issues solved | 8 (0.7%) |